A nationwide shortage of Adderall, the drug commonly prescribed for Attention-Deficit/Hyperactivity Disorder (ADHD), has dragged on since last October, and the pharmaceutical industry hasn’t been able to catch up.
A nationwide shortage of Adderall, the drug commonly prescribed for Attention-Deficit/Hyperactivity Disorder (ADHD), has dragged on since last October, and the pharmaceutical industry hasn’t been able to catch up.
A nationwide shortage of Adderall, the drug commonly prescribed for Attention-Deficit/Hyperactivity Disorder (ADHD), has dragged on since last October, and the pharmaceutical industry hasn’t been able to catch up.
A nationwide shortage of Adderall, the drug commonly prescribed for Attention-Deficit/Hyperactivity Disorder (ADHD), has dragged on since last October, and the pharmaceutical industry hasn’t been able to catch up.